Breaking Finance News

Smith Nephew PLC (LON:SN) target price held steady at 1,515.00GBX, issued a report today by Jefferies International

Yesterday Smith Nephew PLC (LON:SN) traded 0.14% higher at 1,404.50GBX. The company’s 50-day moving average is 1,367.16GBX and its 200-day moving average is 1,327.10GBX. The last closing price is up 5.72% from the 200-day moving average, compared to the S&P 500 which has increased 0.03% over the same time. 658,822 shares of Smith Nephew PLC traded, down from an avg. volume of 3,444,020

Smith Nephew PLC (LON:SN) had its target price hold steady to 1,515.00GBX by Jefferies International in a report released 10/12/2017. The new target price indicates a possible upside of 0.08% based on the company's last closing price.

Previously on 10/11/2017, Citigroup reported on Smith Nephew PLC (LON:SN) held steady the target price at 1,160.00GBX. At the time, this indicated a possible downside of -0.12%.

See Chart Below

Smith Nephew PLC (LON:SN)

Smith Nephew PLC has a 52 week low of 1,064.91GBX and a 52 week high of 1,416.50GBX with a P/E ratio of 14.29 The company’s market capitalization is currently 0 GBX.

In addition to Jefferies International reporting its stock price target, a total of 14 brokerages have issued a ratings update on the company. The average stock price target is 16.63GBX with 3 brokerages rating the stock a strong buy, 8 brokerages rating the stock a buy, 9 brokerages rating the stock a hold, 0 brokerages rating the stock a underperform, and finally 0 brokerages rating the stock a sell.

Brief Synopsis On Smith Nephew PLC (LON:SN)

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *